Tumor-penetrating peptides: a shift from magic bullets to magic guns

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Targeted drug delivery to tumors aims to improve cancer therapy and detection.
• Efficient drug distribution deep into tumor tissue remains a significant challenge.

Purpose of the Study:

• To identify and characterize a peptide capable of selective tumor targeting and deep tissue penetration.
• To evaluate the peptide's efficacy in delivering various therapeutic and diagnostic agents.

Main Methods:

• A peptide was designed to target alpha(V) integrins via an arginine-glycine-aspartate (RGD) motif.
• Upon local proteolysis, a secondary motif was exposed, binding to the neuropilin-1 receptor to increase vascular permeability.
• The peptide's delivery capabilities were tested when conjugated to payloads or co-administered with other agents.

Main Results:

• The peptide selectively binds to alpha(V) integrins at the tumor site.
• Post-proteolysis, it binds neuropilin-1, enhancing tumor vascular permeability and allowing deeper penetration.
• Effective delivery and distribution were achieved for various agents, including small molecules, nanoparticles, and antibodies.

Conclusions:

• A single peptide can effectively target tumors and facilitate deep drug penetration.
• This peptide represents a versatile platform for enhancing anticancer therapies and diagnostic imaging.
• Its efficacy is demonstrated both in conjugated form and through co-administration, offering flexible therapeutic strategies.